Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Acorda Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 34 | 1 | 35 | +2 |
| Shares | 3.37M | 22.6K | 6.65M | +3.30M (+98.6%) |
| Value | $5.42M | $36.0K | $3.08M | −$2.30M (−42.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Acorda Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Davidson Kempner Capital Management LP | 2,395,668 | $1.11M | 0.02% |
| Virtu Financial LLC | 145,318 | $68.0K | 0.01% |
| Prudential Financial Inc | 60,200 | $28.0K | 0.00% |
| Susquehanna International Group, LLP | 45,880 | $21.0K | 0.00% |
| HRT Financial LP | 39,319 | $18.0K | 0.00% |
| Two Sigma Securities, LLC | 27,692 | $13.0K | 0.00% |
| Verition Fund Management LLC | 13,641 | $6.00K | 0.00% |
| Ergoteles LLC | 13,300 | $6.00K | 0.00% |
| Simon Quick Advisors, LLC | 14,211 | $6.00K | 0.00% |
Sold out (7)
Institutions that held Acorda Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 464,276 | $747.0K |
| Dimensional Fund Advisors LP | 19,752 | $32.0K |
| Jane Street Group, LLC | 13,505 | $22.0K |
| Citigroup Inc | 1,658 | $3.00K |
| Federated Hermes, Inc. | 755 | $1.00K |
| Capital Advisors, Ltd. LLC | 37 | $0 |
| Private Capital Group, LLC | 10 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Acorda Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 22,600 | $36.0K |